RAB31 and gastric adenocarcinoma: Simultaneous treatment with cisplatin and Rab31 knockdown significantly reduced tumor cell proliferation (Fig. 5F, G), suggesting that Rab31 is a potential therapeutic target that can be paired with cisplatin treatment for STAD.